Owkin logo

Owkin

Verified

Owkin is an AI biotechnology company focused on accelerating drug discovery and research in medicine. It combines a large network of patient data, an autonomous AI scientist called K Pro, and wet lab validation to help generate and test biological hypotheses. Owkin works with biopharma companies on questions across oncology, neuroscience, cardiology, stroke, pulmonary disease, obesity, and ageing research. The tool is aimed at pharmaceutical companies, research institutions, and biomedical scientists looking to speed up drug R&D using AI combined with real patient data and lab validation, rather than individual consumers or general businesses.

Visit Official Website

Owkin at a glance

What it is
Owkin is an AI biotechnology company focused on accelerating drug discovery and research in medicine.
Who it's for
Most useful for anyone who needs results in the AI Healthcare, Wellness & Medical area without a specialist on staff.
Primary use case
Our vision is a world where R&D is automated and research is directly connected to care.
  • CategoryAI Healthcare, Wellness & Medical
  • PricingFree Tier
  • Starting priceFree, paid plans available
  • Credit cardNo credit card required
  • Foundation modelMulti-model
  • Bring your own keySupported
  • RatingNo reviews yet. Be the first to rate.

Video Spot

No creator video yet. “Stop Getting Lost in the AI Labyrinth” — the official Zoipi platform showcase.

Overview

Owkin is an AI biotechnology company focused on accelerating drug discovery and research in medicine. It combines a large network of patient data, an autonomous AI scientist called K Pro, and wet lab validation to help generate and test biological hypotheses. Owkin works with biopharma companies on questions across oncology, neuroscience, cardiology, stroke, pulmonary disease, obesity, and ageing research. The tool is aimed at pharmaceutical companies, research institutions, and biomedical scientists looking to speed up drug R&D using AI combined with real patient data and lab validation, rather than individual consumers or general businesses.

Our vision is a world where R&D is automated and research is directly connected to care. Discover how Owkin's AI Scientist is making this a reality.

In detail

Owkin is an AI-driven biotechnology platform built to automate parts of drug research and development by connecting large-scale patient data with an AI system and laboratory validation. The company states its goal is a world where R&D is automated and directly connected to patient care, and it positions itself as working on some of the most pressing open questions in medicine across areas like oncology, neurodegeneration, cardiology, stroke, pulmonary disease, obesity, and ageing.

Owkin is built for biopharma companies, research institutions, and investors rather than individual consumers. According to the listing, the platform is used today by major pharmaceutical companies including AstraZeneca, Sanofi, Servier, and Boehringer Ingelheim, who use K Pro to support their drug discovery and development work.

The platform works through three main pillars. First, a network of AI-ready patient data drawn from millions of patients across hundreds of hospitals, described as multimodal and longitudinal. Second, an autonomous AI system called K Pro, which combines multiple agents, tools, and skills informed by a network of key opinion leaders, and can work across the full drug development pipeline either autonomously or alongside human researchers. Third, organoid and chemistry wet lab validation, where K Pro's best hypotheses are tested by biomedical experts in a physical lab, with results feeding back into the AI system as reusable workflows.

What differentiates Owkin, based on the available information, is this closed loop between large-scale real patient data, AI-generated hypotheses, and physical lab validation, rather than offering AI modeling alone. The company frames its approach as moving research from data directly to drugs, with insights from validation continually improving the AI system's future outputs.

Prospective users interested in working with Owkin can book a demo to see how K Pro could apply to their own drug R&D questions, or get in touch as a frontier lab or investor interested in the company's broader mission.

Common uses

  • Identifying biomarkers that predict patient response or resistance to specific drug treatments
  • Discovering new therapeutic targets in areas like oncology, neurodegeneration, and cardiology
  • Supporting pharmaceutical companies in drug discovery and development pipelines
  • Validating AI-generated biological hypotheses through wet lab experiments
  • Segmenting patient populations into biological subtypes for more targeted therapies

Pros

  • Combines large-scale real patient data with AI modeling and physical lab validation
  • Already used by several large pharmaceutical companies
  • Covers a broad range of disease areas including oncology, cardiology, and neuroscience
  • Offers both autonomous and collaborative modes of use for research teams

Cons

  • Built for pharmaceutical and research organizations rather than individual users or small teams
  • No publicly stated pricing details beyond a general freemium label
  • Requires booking a demo to learn how the platform applies to specific use cases
  • Highly specialized focus on drug R&D limits applicability outside biomedical research

Generated from the listing's details and not yet checked by a Zoipi editor.

Key Features

  • Patient Data Network: access to a large network of multimodal, longitudinal patient data drawn from many hospitals
  • K Pro AI Scientist: an autonomous AI system combining multiple agents, tools, and skills across the drug development pipeline
  • Autopilot or co-pilot modes: K Pro can work independently or alongside human researchers
  • Wet lab validation: organoid and chemistry experiments validate AI-generated hypotheses
  • Feedback loop: validation results feed back into K Pro as reusable workflows for future research
  • Open research questions: Owkin publicly tracks progress on specific medical questions across disease areas

Best For

  • People who spend real hours each week on ai healthcare, wellness & medical
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option

Pricing Model

Free Tier. Generous ongoing free tier you can start with, no credit card needed. Paid plans unlock higher limits.

Pricing Breakdown

Starting price
Free, paid plans available
Free trial / credits
Ongoing free tier, no time limit
Credit card
No credit card required
Freemium

Screenshots

Live preview of Owkin's website.

Frequently asked questions

Owkin is used for AI-driven drug discovery and research, combining patient data, an AI system called K Pro, and wet lab validation to identify biomarkers, drug targets, and patient subgroups across diseases like cancer, neurodegeneration, and cardiology.

Community Reviews & Discussion

0 reviews · replies are moderated before they appear.

  • No reviews yet — be the first to review Owkin.